EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy

Changfang Luo, Zhuojun Dai, Wanhong He, Yanqiu He, Ping Yang, Mengting Huang, Junle Li, Yong Xu, Wei Huang

Frontiers in Nutrition · 23.01.2025 · 12

DOI: 10.3389/fnut.2025.1508695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 23.01.2025. Verfasst von Changfang Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diet has been proven to have significant impacts on the pathogenesis and treatment of osteoporosis. This review attempts to elucidate the current progress and controversy surrounding the ketogenic diet (KD) and β-hydroxybutyrate (BHB) in osteoporosis and offers a novel perspective on the prevention and treatment of osteoporosis. The ketogenic diet has been broadly used in the treatment of epilepsy, diabetes, obesity, and certain neoplasms by triggering ketone bodies, mainly BHB. However, in most osteoporosis-related clinical and preclinical studies, the ketogenic diet has demonstrated the detrimental effects of inhibiting bone accumulation and damaging bone microarchitecture. In contrast, BHB is thought to ameliorate osteoporosis by promoting osteoblastogenesis and inhibiting osteoclastogenesis. The main purpose of this review is to summarize the current research progress and hope that more basic and clinical experiments will focus on the similarities and differences between ketogenic diet (KD) and BHB in osteoporosis.

Schlagwörter

Stichwörter der Autor:innen

ketogenic dietosteoblastosteoclastosteoporosisβ-hydroxybutyrate

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.
  • Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, China.
  • Sichuan Clinical Research Center for Diabetes and Metabolic Diseases, Luzhou, Sichuan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Luo, C., Dai, Z., He, W., He, Y., Yang, P., Huang, M., Li, J., Xu, Y., & Huang, W. (2025). Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1508695

Vancouver

Luo C, Dai Z, He W, He Y, Yang P, Huang M, et al. Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1508695

BibTeX
@article{Luo2025,
  author = {Luo, Changfang and Dai, Zhuojun and He, Wanhong and He, Yanqiu and Yang, Ping and Huang, Mengting and Li, Junle and Xu, Yong and Huang, Wei},
  title = {Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1508695}
}
Kostenlos starten →